These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 420037)

  • 1. Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion.
    Lal S; Nair NP; Cervantes P; Pulman J; Guyda H
    Acta Psychiatr Scand; 1979 Feb; 59(2):173-9. PubMed ID: 420037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia.
    Nair NP; Lal S; Cervantes P; Yassa R; Guyda H
    Neuropsychobiology; 1979; 5(3):136-42. PubMed ID: 431802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced growth hormone and prolactin responses in schizophrenia research.
    Lal S; Nair NP; Iskandar HI; Thavundayil JX; Etienne P; Wood PL; Guyda H
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):631-7. PubMed ID: 6131495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lithium on hypothalamic-pituitary dopaminergic function.
    Lal S; Nair NP; Guyda H
    Acta Psychiatr Scand; 1978 Jan; 57(1):91-6. PubMed ID: 636903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCK-33 antagonizes apomorphine-induced growth hormone secretion and increases basal prolactin levels in man.
    Nair NP; Lal S; Thavundayil JX; Wood PL; Etienne P; Guyda H
    Neuropeptides; 1984 Jun; 4(4):281-91. PubMed ID: 6472582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of choline on central dopaminergic function in normal subjects.
    Lal S; Etienne P; Thavundayil J; Nair NP; Collier B; Rastogi R; Guyda H; Schwartz G
    J Neural Transm; 1981; 50(1):29-37. PubMed ID: 7205247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication.
    Lal S; Nair NP; Thavundayil JX; Tawar V; Quirion R; Guyda H
    J Neural Transm Gen Sect; 1991; 85(2):157-64. PubMed ID: 1930878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
    Ettigi P; Nair NP; Lal S; Cervantes P; Guyda H
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):870-6. PubMed ID: 993808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine evaluation of CCK-peptides on dopaminergic function in man.
    Lal S; Nair NP; Eugenio H; Thavundayil J; Lizondo E; Wood PL; Etienne P; Guyda H
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):537-44. PubMed ID: 6320299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormones, dopamine receptors and schizophrenia.
    Meltzer HY; Busch D; Fang VS
    Psychoneuroendocrinology; 1981; 6(1):17-36. PubMed ID: 7244055
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth hormone, prolactin and cortisol nyctohemeral variations during naloxone-induced opiate receptor blockade in man.
    Delitala G; Giusti M; Rodriguez G; Mazzocchi G; Ferrini S; Baccelliere L; Montano V; Rosadini G; Giordano G
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):321-6. PubMed ID: 6287782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of domperidone on apomorphine-induced growth hormone secretion in normal men.
    Lal S; Nair NP; Iskandar HL; Etienne P; Wood PL; Schwartz G; Guyda H
    J Neural Transm; 1982; 54(1-2):75-84. PubMed ID: 7108512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of L-tryptophan on apomorphine-induced growth hormone secretion in normal subjects.
    Lal S; Young SN; Cervantes P; Guyda H
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):331-5. PubMed ID: 7208604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of some peptides on dopaminergic function in man.
    Lal S; Nair NP; Isaac I; Thavundayil J; Guyda H
    J Neural Transm Suppl; 1990; 29():173-81. PubMed ID: 2113567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone inhibits prolactin and growth hormone release induced by intracellular glucopenia in the rats.
    Okajima T; Motomatsu T; Kato K; Ibayashi H
    Life Sci; 1980 Sep; 27(9):755-60. PubMed ID: 7412502
    [No Abstract]   [Full Text] [Related]  

  • 16. CCK-8 antagonizes apomorphine-induced growth hormone secretion in normal subjects.
    Nair NP; Lal S; Eugenio H; Lizondo E; Thavundayil JX; Wood PL; Etienne P; Guyda H
    Horm Metab Res; 1986 Jan; 18(1):53-5. PubMed ID: 3949282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of naloxone to reverse apomorphine effects in humans.
    Rowbotham MC; Joseph MS; Jones RT; Keil LC
    Psychoneuroendocrinology; 1983; 8(1):95-102. PubMed ID: 6308702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of apomorphine hydrochloride administration on serum concentrations of prolactin and growth hormone in cattle.
    Gorewit RC
    Experientia; 1981 Feb; 37(2):204-6. PubMed ID: 7238762
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of opiate, dopaminergic, and adrenergic systems in the hypothalamo-pituitary dysfunction in obesity.
    Baranowska B; Singh SP; Soszynski P; Nowakowski J; Jeske W
    Acta Endocrinol (Copenh); 1987 Oct; 116(2):221-8. PubMed ID: 2889310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sleep deprivation on dopamine receptor function in normal subjects.
    Lal S; Thavundayil J; Nair NP; Etienne P; Rastogi R; Schwartz G; Pulman J; Guyda H
    J Neural Transm; 1981; 50(1):39-45. PubMed ID: 7205248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.